Investor Relations

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company committed to developing and delivering life-changing treatments for orphan diseases.

View all »Events & Presentations

Sep 30, 2014 at 9:00 AM ET
Hyperion Therapeutics Corporate Briefing

Oct 1, 2014 at 9:15 AM ET
Leerink Rare Disease Roundtable

Category: